Eleftheria Kampouri
Overview
Explore the profile of Eleftheria Kampouri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu W, Kampouri E, Bui J, Sekhon M, Tercero A, Finlay D, et al.
Mol Ther Methods Clin Dev
. 2024 Dec;
32(4):101361.
PMID: 39624798
Low levels and function of natural killer (NK) cells are associated with increased coronavirus disease 2019 (COVID-19) severity. NK cell immunotherapy may improve immune function to reduce infection severity. We...
2.
Reynolds G, Smibert O, Kampouri E
Transpl Infect Dis
. 2024 Oct;
26(6):e14395.
PMID: 39403976
No abstract available.
3.
Kampouri E, Reynolds G, Teh B, Hill J
Curr Opin Infect Dis
. 2024 Oct;
37(6):526-535.
PMID: 39361275
Purpose Of Review: Infections are the leading cause of non-relapse mortality following chimeric antigen receptor (CAR)-T-cell therapy, with viral infections being frequent both in the early and late phases post-infusion....
4.
Kampouri E, Damas J, Kusejko K, Ledergerber B, Braun D, Nawej Tshikung O, et al.
AIDS
. 2024 Jul;
38(13):1874-1884.
PMID: 39051627
Objectives: We aimed to determine the prevalence of HIV-related stigma among people with HIV (PWH) in Switzerland. Design: A cross-sectional multicenter study nested within the Swiss HIV Cohort Study (SHCS)....
5.
Zamora D, Xie H, Sadowska-Klasa A, Kampouri E, Biernacki M, Ueda Oshima M, et al.
Blood Adv
. 2024 Jun;
8(17):4568-4580.
PMID: 38924728
Cytomegalovirus (CMV) disease occurs occasionally before allogeneic hematopoietic cell transplantation (HCT) and is associated with poor post-HCT outcomes; however, the impact of pre-HCT CMV reactivation is unknown. Pre-HCT CMV reactivation...
6.
Little J, Kampouri E, Friedman D, McCarty T, Thompson 3rd G, Kontoyiannis D, et al.
Open Forum Infect Dis
. 2024 Jun;
11(6):ofae133.
PMID: 38887472
Chimeric antigen receptor (CAR) T-cell therapy is a novel immunotherapy approved for the treatment of hematologic malignancies. This therapy leads to a variety of immunologic deficits that could place patients...
7.
Kampouri E, Little J, Crocchiolo R, Hill J
Curr Opin Infect Dis
. 2024 May;
37(4):245-253.
PMID: 38726832
Purpose Of Review: Viral infections continue to burden allogeneic hematopoietic cell transplant (HCT) recipients. We review the epidemiology, diagnosis, and management of human herpesvirus (HHV)-6, HHV-8 and parvovirus B19 following...
8.
Kampouri E, Handley G, Hill J
Viruses
. 2024 Apr;
16(4).
PMID: 38675841
HHV-6B reactivation affects approximately half of all allogeneic hematopoietic cell transplant (HCT) recipients. HHV-6B is the most frequent infectious cause of encephalitis following HCT and is associated with pleiotropic manifestations...
9.
Kampouri E, Krantz E, Xie H, Ibrahimi S, Kiem E, Sekhon M, et al.
Blood
. 2024 Apr;
144(5):490-495.
PMID: 38635788
Human herpesvirus 6B (HHV-6B) reactivation and disease are increasingly reported after chimeric antigen receptor (CAR) T-cell therapy (CARTx). HHV-6 reactivation in the CAR T-cell product was recently reported, raising questions...
10.
Kampouri E, Boeckh M, Hill J
Clin Infect Dis
. 2024 Feb;
79(5):1319-1320.
PMID: 38306247
No abstract available.